We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.1B
AUM Growth
-$3.19M
Cap. Flow
+$7.15M
Cap. Flow %
0.65%
Top 10 Hldgs %
43.88%
Holding
196
New
25
Increased
25
Reduced
18
Closed
22

Top Buys

Rank Stock Value
1
ROCC
Ranger Oil Corporation Class A Common Stock
ROCC
+$19.4M
2
HSACU
Health Sciences Acquisitions Corporation Units
HSACU
+$8.33M
3
ADNT icon
Adient
ADNT
+$5.66M
4
ROAN
Roan Resources, Inc.
ROAN
+$5.33M
5
GM icon
General Motors
GM
+$3.75M

Top Sells

Rank Stock Value
1
QURE icon
uniQure
QURE
+$15.9M
2
PCG icon
PG&E
PCG
+$12.8M
3
STNG icon
Scorpio Tankers
STNG
+$10.5M
4
TRUE
TrueCar
TRUE
+$6.45M
5
BX icon
Blackstone
BX
+$5.95M

Sector Composition

Rank Sector Weight
1 Healthcare 22.77%
2 Consumer Discretionary 14.6%
3 Financials 5.74%
4 Energy 5.41%
5 Communication Services 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSX icon
101
Diana Shipping
DSX
$266M
$902K 0.08%
389,938
– –
NRCG.WS
102
DELISTED
NRC Group Holdings Corp.
NRCG.WS
$888K 0.08%
537,500
– –
ELVT
103
DELISTED
Elevate Credit, Inc.
ELVT
$881K 0.08%
213,844
-196,156
-48% -$875K
TCRT icon
104
Alaunos Therapeutics
TCRT
$4.64M
$875K 0.08%
1,000
-333
-25% -$229K
AGTC
105
DELISTED
Applied Genetic Technologies Corporation
AGTC
$758K 0.07%
200,000
– –
ARYAW
106
DELISTED
ARYA Sciences Acquisiton Corp. Warrant
ARYAW
$750K 0.07%
500,000
– –
PVLA
107
Palvella Therapeutics
PVLA
$2.05B
$706K 0.06%
1,878
– –
KDMN
108
DELISTED
Kadmon Holdings, Inc.
KDMN
$690K 0.06%
334,900
– –
NESRW
109
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
$616K 0.06%
725,000
– –
NM
110
DELISTED
Navios Maritime Holdings Inc.
NM
$584K 0.05%
130,500
-4,500
-3% -$17K
AFMD
111
DELISTED
Affimed
AFMD
$575K 0.05%
+20,000
New +$674K
GEF.B icon
112
Greif Class B
GEF.B
$4.13B
$520K 0.05%
11,910
– –
ONCS
113
DELISTED
OncoSec Medical Incorporated
ONCS
$476K 0.04%
8,545
+7,181
+526% +$691K
XBIT icon
114
XBiotech
XBIT
$68.6M
$455K 0.04%
+60,000
New +$522K
SLS icon
115
SELLAS Life Sciences
SLS
$1.99B
$408K 0.04%
72,500
+47,000
+184% +$1.67M
TTPH
116
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$403K 0.04%
42,000
– –
ELDN icon
117
Eledon Pharmaceuticals
ELDN
$255M
$326K 0.03%
+17,950
New +$785K
LTRYW icon
118
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$916
$299K 0.03%
1,993,750
– –
MMDMR
119
DELISTED
Modern Media Acquisition Corp. Right
MMDMR
$290K 0.03%
1,000,000
– –
BRACW
120
DELISTED
Black Ridge Acquisition Corp. Warrant
BRACW
$287K 0.03%
700,000
– –
CYPH
121
Cypherpunk Technologies Inc
CYPH
$64M
$268K 0.02%
15,014
– –
VTIQW
122
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
$238K 0.02%
500,000
– –
TMCXW
123
DELISTED
Trinity Merger Corp. Warrant
TMCXW
$230K 0.02%
700,000
– –
KERNW
124
DELISTED
Akerna Corp Warrant
KERNW
$223K 0.02%
+75,000
New +$212K
TIBRW
125
DELISTED
Tiberius Acquisition Corporation Warrant
TIBRW
$205K 0.02%
450,000
– –
3 4
5
6 7

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, 683 Capital Management held 196 positions worth $1.1B, down 0.29% from $1.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

683 Capital Management's Q2 2019 filing shows 25 new, 25 increased, 18 reduced and 22 closed positions. Its largest new stake was Ranger Oil Corporation Class A Common Stock: 520,000 shares worth $16M. The largest sale was uniQure, an estimated $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • 683 Capital Management's largest Q2 2019 buy was Ranger Oil Corporation Class A Common Stock: 520,000 shares worth $16M.
  • 683 Capital Management added most to Adient in Q2 2019, an estimated $5.66M increase.
  • 683 Capital Management's biggest Q2 2019 reduction was uniQure, cutting an estimated $15.9M.
  • 683 Capital Management fully exited Blackstone in Q2 2019, selling an estimated $5.95M.
  • 683 Capital Management's ten largest holdings make up 44% of its $1.1B portfolio in Q2 2019.
  • 683 Capital Management opened 25 new positions and closed 22 in Q2 2019.
  • 683 Capital Management's portfolio value fell 0.29% quarter-over-quarter to $1.1B.

Based on 683 Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.